Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Intas Pharmaceuticals Limited | Ahmedabad, India | Makes it and tests it | Serious problems, FDA actionDec 2, 2022 · 7 inspections, 1 with FDA action |
Recalls
- Oct 1, 2024 · Class II · Accord Healthcare, Inc.
Failed Impurities/Degradation Specifications.
Lots: Lot #: P2202009, Exp. Date: 03/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cisplatin: every company that makes it
- Form
- injection, intravenous
- Strength
- 1 mg per 1 mL
- Approval
- ANDA ANDA206774
- On the market since
- Dec 13, 2016
- Package NDCs
16729-288-1116729-288-38- Official label
- DailyMed (National Library of Medicine), updated Dec 3, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?